Structure and Message in Trobriand cricket

Ce texte est une version révisée des « Notes » afférentes à Trobriand cricket, film très connu parmi les anthropologues, qui fut réalisé à l’époque où leur attention se centrait (et c’est encore souvent le cas) sur le « message » décelable dans les comportements sociaux. Le thème principal de l’article se résume ainsi : comment les messages ont-ils été construits et insérés dans l’ensemble du documentaire, par le biais des relations entre ses bases constitutives, les images, le discours ? En formalisant quelque peu, l’auteur rend manifestes certains de ces messages du film. Bien sûr, ceux que perçoivent de facto un spectateur ou un public donnés relèvent d’un autre registre et restent ouverts à des recherches ultérieures.Structure and Message in Trobriand cricketThis paper is a modified version of the « Notes » to accompany the much talked-about film Trobriand cricket, that was made during a period in anthropology when attention was, and still is, focused on the message-bearing aspects of social behaviour. This dominant concern expressed in the article is about how messages were built into the whole film through the interrelations of its basic parts, images, and words. The author makes explicit, in a moderately formalized way, what some of the intended messages of Trobriand cricket are. The actual message to any given viewer or audience are, of course, another matter, and open to further investigation.El cricket de las Islas Trobriand : estructura y mensajeEste texto lo constituye una versión modificada de las « Notas » que respectan a Trobriand cricket, una película de mucha fama entre los antropólogos, que fue realizada cuando los trabajos de estos últimos enfocaban el « mensaje » traído por las conductas sociales (enfoque que sigue siendo vigente, a menudo). Una cuestión sintetiza el tema del artículo : ¿ De qué manera los mensajes han sido construídos e incorporados en el conjunto del filme, mediante las interrelaciones de sus partes básicas, de las imágenes y de las palabras ? El autor elucida algunos mensajes del documental, formalizándolos en cierta medida. Por supuesto, los que perciben tal espectador o tal público son datos distintos que quedan abiertos para investigaciones ulteriores

Intentional versus unintentional nitrogen use in the United States : trends, efficiency and implications

© The Author(s), 2012. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Biogeochemistry 114 (2013): 11-23, doi:10.1007/s10533-012-9801-5.Human actions have both intentionally and unintentionally altered the global economy of nitrogen (N), with both positive and negative consequences for human health and welfare, the environment and climate change. Here we examine long-term trends in reactive N (Nr) creation and efficiencies of Nr use within the continental US. We estimate that human actions in the US have increased Nr inputs by at least ~5 times compared to pre-industrial conditions. Whereas N2 fixation as a by-product of fossil fuel combustion accounted for ~1/4 of Nr inputs from the 1970s to 2000 (or ~7 Tg N year−1), this value has dropped substantially since then (to <5 Tg N year−1), owing to Clean Air Act amendments. As of 2007, national N use efficiency (NUE) of all combined N inputs was equal to ~40 %. This value increases to 55 % when considering intentional N inputs alone, with food, industrial goods, fuel and fiber production accounting for the largest Nr sinks, respectively. We estimate that 66 % of the N lost during the production of goods and services enters the air (as NO x , NH3, N2O and N2), with the remaining 34 % lost to various waterways. These Nr losses contribute to smog formation, acid rain, eutrophication, biodiversity declines and climate change. Hence we argue that an improved national NUE would: (i) benefit the US economy on the production side; (ii) reduce social damage costs; and (iii) help avoid some major climate change risks in the future.This work resulted from a workshop supported by NSF Research Coordination Network Awards DEB-0443439 and DEB-1049744 and by the David and Lucille Packard Foundation

Urban Dispersion Program: Urban Measurements Applied to Emergency Response

Air motions in and around cities are highly complex, and the increasing threat of harmful releases into urban atmospheres makes advancing the state-of-science of understanding and modeling atmospheric flows and dispersion in and around cities essential. The four-year Urban Dispersion Program (UDP) funded primarily by the U.S. Department of Homeland Security and the Defense Threat Reduction Agency has recently been completed. The program’s primary focus was to conduct tracer and meteorological field studies in Manhattan to improve our understanding of flow and dispersion of airborne contaminants through and around the deep street canyons of New York City, including outdoor-indoor-subway exchange mechanisms. Additionally, urban dispersion models are being validated and first-responder guidance are being refined using data collected during the two UDP field studies. Pacific Northwest National Laboratory led several government laboratories, universities and private companies in conducting the two UDP field studies. The first study was a small-scale study that investigated dispersion in the immediate vicinity of the Madison Square Garden during March 2005 (MSG05), while the second UDP study was an extensive study conducted during August 2005 in Midtown Manhattan (MID05). A brief overview of the UDP field studies will be given followed by a discussion of some limitations of current urban models in simulating dispersion in urban areas. Some first-responder guidance based on findings from recent urban field studies will also be presented

Evaluating telehealth lifestyle therapy versus telehealth psychotherapy for reducing depression in adults with COVID-19 related distress: the curbing anxiety and depression using lifestyle medicine (CALM) randomised non-inferiority trial protocol

BACKGROUND: There is increasing recognition of the substantial burden of mental health disorders at an individual and population level, including consequent demand on mental health services. Lifestyle-based mental healthcare offers an additional approach to existing services with potential to help alleviate system burden. Despite the latest Royal Australian New Zealand College of Psychiatrists guidelines recommending that lifestyle is a ‘first-line’, ‘non-negotiable’ treatment for mood disorders, few such programs exist within clinical practice. Additionally, there are limited data to determine whether lifestyle approaches are equivalent to established treatments. Using an individually randomised group treatment design, we aim to address this gap by evaluating an integrated lifestyle program (CALM) compared to an established therapy (psychotherapy), both delivered via telehealth. It is hypothesised that the CALM program will not be inferior to psychotherapy with respect to depressive symptoms at 8 weeks. METHODS: The study is being conducted in partnership with Barwon Health’s Mental Health, Drugs & Alcohol Service (Geelong, Victoria), from which 184 participants from its service and surrounding regions are being recruited. Eligible participants with elevated psychological distress are being randomised to CALM or psychotherapy. Each takes a trans-diagnostic approach, and comprises four weekly (weeks 1-4) and two fortnightly (weeks 6 and 8) 90-min, group-based sessions delivered via Zoom (digital video conferencing platform). CALM focuses on enhancing knowledge, behavioural skills and support for improving dietary and physical activity behaviours, delivered by an Accredited Exercise Physiologist and Accredited Practising Dietitian. Psychotherapy uses cognitive behavioural therapy (CBT) delivered by a Psychologist or Clinical Psychologist, and Provisional Psychologist. Data collection occurs at baseline and 8 weeks. The primary outcome is depressive symptoms (assessed via the Patient Health Questionnaire-9) at 8 weeks. Societal and healthcare costs will be estimated to determine the cost-effectiveness of the CALM program. A process evaluation will determine its reach, adoption, implementation and maintenance. DISCUSSION: If the CALM program is non-inferior to psychotherapy, this study will provide the first evidence to support lifestyle-based mental healthcare as an additional care model to support individuals experiencing psychological distress. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12621000387820, Registered 8 April 2021

4-H driving manual

Use this 4-H Driving Manual as you learn how to train your animal, fit the harness properly, and drive your animal safely. The manual outlines one of several accepted ways of training

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Do I dare preach about sexual sin, part D

https://place.asburyseminary.edu/atsconferences/1573/thumbnail.jp

Do I dare preach about sexual sin, part A

https://place.asburyseminary.edu/atsconferences/1568/thumbnail.jp

Do I dare preach about sexual sin, part D

https://place.asburyseminary.edu/atsconferences/1574/thumbnail.jp